Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
British Journal of Haematology
|
January 5, 2025
Long-term efficacy and safety of avatrombopag in Chinese children with primary immune thrombocytopenia: A real-world observational study
Nan Wang, Zhifa Wang, Jingjing Liu, et al.
International Journal of Nanomedicine
|
March 24, 2025
Layered Double Hydroxide Nanoparticles Loaded with Resveratrol Inhibit Glycolysis and Show Efficacy in the Treatment of Breast Cancer
Chenchen Geng, Liuyang Yan, Yunhao Li, et al.
Journal of Thrombosis and Haemostasis : JTH
|
December 16, 2023
Machine learning models developed and internally validated for predicting chronicity in pediatric immune thrombocytopenia
Jingyao Ma, Chang Cui, Yongqiang Tang, et al.
Research and Practice in Thrombosis and Haemostasis
|
April 1, 2025
Stepwise response-guided treatment protocol superior to thrombopoietin receptor agonist-based second-line therapy for severe persistent/chronic immune thrombocytopenia: a multicenter prospective study from China
Lingling Fu, Xi Lin, Zhenping Chen, et al.
Annals of Hematology
|
September 11, 2025
Multicenter, real-world observational study of AVA therapy following ELT/HET switching in Chinese children with persistent/chronic primary ITP
Jingjing Liu, Zhifa Wang, Nan Wang, et al.
Bioorganic Chemistry
|
March 14, 2026
Layered double hydroxide nanoplatform synergizes with sonodynamic therapy to induce dual activation of cuproptosis and ferroptosis for breast cancer treatment
Qiyu Zhu, Zhifa Wang, Lu Xia, et al.
British Journal of Haematology
|
February 16, 2024
Efficacy and safety of avatrombopag in Chinese children with persistent and chronic primary immune thrombocytopenia: A multicentre observational retrospective study in China
Zhifa Wang, Aijun Zhang, Zhongjin Xu, et al.
British Journal of Haematology
|
July 16, 2025
Machine learning to forecast rituximab responses for paediatric immune thrombocytopenia: Forging a path towards personalized medical care
Jingyao Ma, Chang Cui, Juntao Ouyang, et al.
Research and Practice in Thrombosis and Haemostasis
|
December 11, 2025
Rituximab-first versus eltrombopag monotherapy in pediatric persistent/chronic immune refractory thrombocytopenia after first-line therapy: a prospective multicenter cohort study
Jingyao Ma, Zhifa Wang, Juntao Ouyang, et al.
Annals of Hematology
|
June 8, 2026
Prediction of avatrombopag-induced thrombocytosis in pediatric immune thrombocytopenia: an AI-based real-world study
Xi Lin, Yuntian Wang, Yunqi Zhu, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
British Journal of Haematology
|
January 5, 2025
Long-term efficacy and safety of avatrombopag in Chinese children with primary immune thrombocytopenia: A real-world observational study
Nan Wang, Zhifa Wang, Jingjing Liu, et al.
International Journal of Nanomedicine
|
March 24, 2025
Layered Double Hydroxide Nanoparticles Loaded with Resveratrol Inhibit Glycolysis and Show Efficacy in the Treatment of Breast Cancer
Chenchen Geng, Liuyang Yan, Yunhao Li, et al.
Journal of Thrombosis and Haemostasis : JTH
|
December 16, 2023
Machine learning models developed and internally validated for predicting chronicity in pediatric immune thrombocytopenia
Jingyao Ma, Chang Cui, Yongqiang Tang, et al.
Research and Practice in Thrombosis and Haemostasis
|
April 1, 2025
Stepwise response-guided treatment protocol superior to thrombopoietin receptor agonist-based second-line therapy for severe persistent/chronic immune thrombocytopenia: a multicenter prospective study from China
Lingling Fu, Xi Lin, Zhenping Chen, et al.
Annals of Hematology
|
September 11, 2025
Multicenter, real-world observational study of AVA therapy following ELT/HET switching in Chinese children with persistent/chronic primary ITP
Jingjing Liu, Zhifa Wang, Nan Wang, et al.
Bioorganic Chemistry
|
March 14, 2026
Layered double hydroxide nanoplatform synergizes with sonodynamic therapy to induce dual activation of cuproptosis and ferroptosis for breast cancer treatment
Qiyu Zhu, Zhifa Wang, Lu Xia, et al.
British Journal of Haematology
|
February 16, 2024
Efficacy and safety of avatrombopag in Chinese children with persistent and chronic primary immune thrombocytopenia: A multicentre observational retrospective study in China
Zhifa Wang, Aijun Zhang, Zhongjin Xu, et al.
British Journal of Haematology
|
July 16, 2025
Machine learning to forecast rituximab responses for paediatric immune thrombocytopenia: Forging a path towards personalized medical care
Jingyao Ma, Chang Cui, Juntao Ouyang, et al.
Research and Practice in Thrombosis and Haemostasis
|
December 11, 2025
Rituximab-first versus eltrombopag monotherapy in pediatric persistent/chronic immune refractory thrombocytopenia after first-line therapy: a prospective multicenter cohort study
Jingyao Ma, Zhifa Wang, Juntao Ouyang, et al.
Annals of Hematology
|
June 8, 2026
Prediction of avatrombopag-induced thrombocytosis in pediatric immune thrombocytopenia: an AI-based real-world study
Xi Lin, Yuntian Wang, Yunqi Zhu, et al.
Page
of 5